ArticleJournal of neural transmission (Vienna, Austria : 1996)2026
Progressive micrographia in Parkinson's disease is associated with multidimensional cognitive and motor features.
Article in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Progressive micrographia, characterized by a gradual reduction in handwriting size, is a common yet incompletely understood feature of Parkinson's disease (PD). It has been associated with both motor and cognitive impairment; however, the clinical characteristics associated with progressive micrographia and the relative contributions of motor and cognitive factors remain unclear. This study aimed to investigate the motor, cognitive, and disease-related clinical features associated with progressive micrographia in PD. Thirty-nine individuals with PD underwent handwriting assessment, the Mini-Mental State Examination, the Movement Disorder Society-Unified Parkinson's Disease Rating Scale Part III, and evaluation of disease duration and levodopa equivalent daily dose. Participants were classified as having progressive micrographia (n = 14) or not having progressive micrographia (n = 25) based on normative handwriting data from healthy older adults. Four machine learning models (logistic regression, elastic net logistic regression, linear support vector machine [SVM], and radial basis function SVM) were evaluated using nested leave-one-out cross-validation. The linear SVM showed the highest numerical area under the receiver operating characteristic curve (AUC; 0.877, 95% CI 0.749-0.977; accuracy = 82.1%). Exploratory feature contribution analyses indicated that classification involved a combination of cognitive and motor features. These findings suggest that progressive micrographia is associated with clinical characteristics extending beyond handwriting impairment alone; however, the identified associations are exploratory and require validation in larger, independent cohorts.
Indexed as
Identifiers
42730821What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.